Earth Science Tech (OTCQB: ETST), a strategic holding company operating across healthcare, pharmacy, technology, telemedicine, real estate, and consumer products, is driving sustainable growth by leveraging artificial intelligence and a focused in-house IT department. The company's approach, detailed during its recent Annual Meeting of Shareholders by Chief Technology Officer Chris Rose, centers on building proprietary technology rather than purchasing third-party solutions.
According to Rose, this strategy has enabled ETST to cut costs, improve operational efficiencies, and expand profit margins within its pharmacy and telemedicine platforms. "We build now instead of buy, supported by advancements in and our leverage of AI," Rose said. "We've built our own ETST-wide software and data platform that ties together the three pharmacies, our curative telehealth business, and My Online Consultation doctor's [services]." This integrated platform allows the company to streamline operations and deliver better patient care.
The company also applies technology in marketing to increase patient and customer retention and drive brand loyalty. By using data-driven insights, ETST can tailor its outreach and improve engagement across its healthcare services. Moreover, the success of its in-house tools has opened a new revenue stream: offering these technologies to other clinics as a white-label service. This move not only monetizes ETST's internal investments but also positions the company as a technology provider in the healthcare sector.
For investors, ETST's focus on technology-driven efficiency and new service offerings could signal a path to sustainable growth and long-term value. The company's ability to innovate internally may reduce reliance on external vendors, lower costs, and create additional income streams. As healthcare and telemedicine continue to evolve, ETST's tech stack could give it a competitive edge. The latest news and updates relating to ETST are available in the company's newsroom at https://ibn.fm/ETST.
The announcement comes as businesses across industries increasingly adopt AI to drive operational improvements. ETST's dedicated IT infrastructure department, led by Rose, has been instrumental in this transformation. By building its own software and data platform, the company ensures that its pharmacy and telemedicine services are seamlessly integrated, potentially enhancing the patient experience and operational agility.
BioMedWire, a specialized communications platform focused on biotechnology, biomedical sciences, and life sciences, originally reported on ETST's developments. As part of its services, BioMedWire provides access to a vast network of wire solutions via InvestorWire to efficiently reach target markets, article and editorial syndication to 5,000+ outlets, enhanced press release enhancement, social media distribution via IBN to millions of followers, and a full array of tailored corporate communications solutions.
For more information, please visit www.BioMedWire.com. Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer.
